ST
BMRN icon

Spot Trading’s BioMarin Pharmaceuticals BMRN Stock Holding History

Spot Trading’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$661K Sell
7,100
-12,400
-64% -$1.1M 0.01% 1445
2017
Q2 		$1.77M Buy
19,500
+15,700
+413% +$1.43M 0.03% 725
2017
Q1 		$334K Buy
3,800
+3,200
+533% +$285K 0.01% 1542
2016
Q4 		$50K Buy
600
+500
+500% +$43K ﹤0.01% 2398
2016
Q3 		$9K Hold
100
– – ﹤0.01% 2897
2016
Q2 		$8K Hold
100
– – ﹤0.01% 3098
2016
Q1 		$8K Sell
100
-95,700
-100% -$7.79M ﹤0.01% 3169
2015
Q4 		$10M Buy
95,800
+86,600
+941% +$9.04M 0.1% 233
2015
Q3 		$969K Buy
9,200
+8,200
+820% +$1.1M 0.01% 1590
2015
Q2 		$137K Sell
1,000
-5,400
-84% -$669K ﹤0.01% 2928
2015
Q1 		$798K Buy
6,400
+5,600
+700% +$593K 0.01% 1774
2014
Q4 		$72K Sell
800
-19,600
-96% -$1.63M ﹤0.01% 3340
2014
Q3 		$1.47M Sell
20,400
-25,200
-55% -$1.66M 0.01% 1777
2014
Q2 		$2.84M Buy
45,600
+1,100
+2% +$66.5K 0.01% 1362
2014
Q1 		$3.04M Buy
44,500
+400
+0.9% +$29.5K 0.02% 1175
2013
Q4 		$3.1M Buy
44,100
+500
+1% +$34K 0.02% 1219
2013
Q3 		$3.15M Buy
43,600
+37,500
+615% +$2.49M 0.02% 1044
2013
Q2 		$340K Buy
+6,100
New +$380K ﹤0.01% 2691

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Spot Trading's BMRN Position: Q3 2017 in Review

Spot Trading increased its BioMarin Pharmaceuticals (BMRN) stake by 342% in Q3 2017, buying an estimated $585K and bringing the position to 8,551 shares worth $796K. The position accounts for 0.01% of the portfolio, ranked #1317.

Spot Trading first reported a position in BMRN in Q2 2013 and has held it in 17 quarters since. The position peaked at $2.49M in Q2 2016. 411 funds tracked by Wall St. Rank hold BMRN as of Q3 2017.

  • Spot Trading held 8,551 shares of BioMarin Pharmaceuticals worth $796K as of Q3 2017.
  • Spot Trading bought 6,616 BioMarin Pharmaceuticals shares in Q3 2017, an estimated $585K.
  • BioMarin Pharmaceuticals made up 0.01% of Spot Trading's portfolio in Q3 2017, its #1317 holding.
  • Spot Trading first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 17 quarters since.
  • Spot Trading's BioMarin Pharmaceuticals position peaked at $2.49M in Q2 2016.
  • 411 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.